| Literature DB >> 25454295 |
Laura M Kulik1, Attasit Chokechanachaisakul2.
Abstract
The burden of hepatocellular carcinoma is rising and anticipated to escalate and while the best chance for long term cure remains transplantation, however the shortage of available organs remains a limitation. Liver directed therapy can serve the role of bridge/downstaging to transplant or as palliative care. Despite an improved overall survival among patients with HCC, due to advancements in surgical techniques, liver directed and systemic therapy, the 5 year overall survival remains low at 18% high-lightening the need for novel therapies. Surveillance for HCC is key to detect disease at an early stage to increase the chances for a potentially curative option.Entities:
Keywords: Diagnosis; Evaluation; Hepatocellular carcinoma; Management; Treatment
Mesh：
Substances：
Year: 2014 PMID： 25454295 DOI： 10.1016/j.cld.2014.09.002
Source DB: PubMed Journal: Clin Liver Dis ISSN： 1089-3261 Impact factor: 6.126